Who Owns Inhibikase Therapeutics, Inc. (IKT)?Hedge Fund & Institutional Holders
Institutional Holders
50
as of Q4 2025
Total Institutional Value
$2.668800022293e+191T
% of Float Held
3.1259916829405653e+277%
QoQ Change in Holders
+7 / -1
Price History
IKT — Biggest New Institutional Buyers This Quarter
| Fund | Action | Shares Added | Value Added |
|---|---|---|---|
| Soleus Capital Management, L.P. | Increased | +4.5M | +$12.0B |
| Siren, L.L.C. | New Position | +5.8M | +$12.0B |
| Sands Capital Alternatives, LLC | Increased | +2.1M | +$8.9B |
| ADAR1 Capital Management, LLC | Increased | +2.8M | +$8.0B |
| Saturn V Capital Management LP | New Position | +3.9M | +$7.9B |
| Blackstone Inc. | Increased | +3.3M | +$7.9B |
| Fairmount Funds Management LLC | Increased | +2.5M | +$7.8B |
| Nantahala Capital Management, LLC | Increased | +1.7M | +$4.5B |
| Stonepine Capital Management, LLC | Increased | +1.6M | +$3.6B |
| Integral Health Asset Management, LLC | New Position | +1.8M | +$3.6B |
| AMERIPRISE FINANCIAL INC | New Position | +1.4M | +$2.0B |
| CITADEL ADVISORS LLC | Increased | +1.2M | +$1.9B |
| Exome Asset Management LLC | New Position | +600K | +$1.2B |
| Persistent Asset Partners Ltd | New Position | +93K | +$191.0M |
| Scientech Research LLC | New Position | +16K | +$32.0M |
IKT — Institutions Reducing or Closing Positions
| Fund | Action | Shares Sold | Value Sold |
|---|---|---|---|
| NORTHERN TRUST CORP | Decreased | -52K | -$606.4M |
| DEUTSCHE BANK AG\ | Decreased | -26K | -$130.4M |
| RHUMBLINE ADVISERS | Decreased | -10K | -$93.2M |
| JPMORGAN CHASE & CO | Decreased | -25K | -$80.0M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Decreased | -24K | -$73.9M |
| UBS Group AG | Decreased | -42K | -$27.8M |
| Tower Research Capital LLC (TRC) | Decreased | -537 | -$11.4M |
| Sterling Capital Management LLC | Decreased | -607 | -$6.2M |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | Decreased | -61 | -$6.1M |
| FMR LLC | Decreased | -48K | -$171K |
| Arax Advisory Partners | Closed Position | -86 | -$139K |
| INTECH INVESTMENT MANAGEMENT LLC | Decreased | -5K | -$51K |
| BNP PARIBAS FINANCIAL MARKETS | Decreased | -3K | -$25K |
| Invesco Ltd. | Decreased | -772 | -$-12.5M |
Top Institutional Holders(Q4 2025)
IKT Institutional Ownership History
| Quarter | Holders | Total Value | Change |
|---|---|---|---|
| Q4 2025 | 73 | $159.7B | +23 |
| Q3 2025 | 50 | $75.4B | +7 |
| Q2 2025 | 43 | $67.5B | -4 |
| Q1 2025 | 47 | $106.2B | +15 |
| Q4 2024 | 32 | $151.0B | +20 |
| Q3 2024 | 12 | $1.0B | -1 |
| Q2 2024 | 13 | $944.9M | +1 |
| Q1 2024 | 12 | $48.9T | — |
Similar Stocks by Institutional Ownership
As of Q4 2025, 50 institutional investors hold IKT (Inhibikase Therapeutics, Inc.). The largest holder is Sands Capital Alternatives, LLC with $26.7B in shares. This quarter, 7 institutions opened new positions and 1 closed their positions.
Frequently Asked Questions
How many hedge funds own IKT?
As of Q4 2025, 50 institutional investors report holding IKT (Inhibikase Therapeutics, Inc.) in their 13F filings.
Who is the largest institutional holder of IKT?
The largest institutional holder of IKT is Sands Capital Alternatives, LLC with $26.7B in shares.
Is institutional ownership of IKT increasing or decreasing?
This quarter, 7 institutions opened new positions in IKT and 1 closed their positions.